Use of a microaxial flow pump led to a lower risk of death in patients with STEMI-related cardiogenic shock in the DanGer Shock trial, although with more adverse events.
Alnylam Presents Positive Results From KARDIA-2 Phase 2 Study Of Zilebesiran At ACC forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
The American College of Cardiology(ACC) and the World Heart Federation’s World Congress of Cardiology (WCC) will conduct their ACC 2024 Annual Scientific
For an all-comer population with any impairment of LV function, an interarterial shunt device missed the primary endpoint in RELIEVE-HF, but benefit was seen with LVEF less than 40%.
Cytokinetics (CYTK) Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.